Recall of Device Recall Absolute shoulder

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Biomet, Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    28433
  • Event Risk Class
    Class 2
  • Event Number
    Z-0777-04
  • Event Initiated Date
    2004-02-23
  • Event Date Posted
    2004-07-20
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2004-04-13
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Prosthesis, Shoulder, Non-Constrained, Metal/Polymer Cemented - Product Code KWT
  • Reason
    The locking ring was not included and the shoulder implanted without the locking ring.
  • Action
    The firm recovered the consigneed units from hospital stocks and issued a letter dated 2/23/04 to the two implanting physicians.

Device

  • Model / Serial
    lot 551440.
  • Product Classification
  • Device Class
    2
  • Implanted device?
    Yes
  • Distribution
    California, Florida, Washington, Germany and Venezuela.
  • Product Description
    Biomet brand Absolute Bi-Polar Shoulder Shell 48 mm w/locking ring; part 113156.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Biomet, Inc., 56 E Bell Dr, Warsaw IN 46582-6989
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    USFDA